Home/Filings/4/0001171843-18-006602
4//SEC Filing

PEHL MICHAEL F. 4

Accession 0001171843-18-006602

CIK 0000722830other

Filed

Sep 17, 8:00 PM ET

Accepted

Sep 18, 2:51 PM ET

Size

5.4 KB

Accession

0001171843-18-006602

Insider Transaction Report

Form 4
Period: 2018-09-14
PEHL MICHAEL F.
DirectorPresident and CEO
Transactions
  • Award

    Stock Options (right to buy)

    2018-09-14+81,80081,800 total
    Exercise: $22.27From: 2019-09-14Exp: 2025-09-14Common Stock, par value $0.01 per share (81,800 underlying)
Footnotes (1)
  • [F1]The reporting person was granted stock options pursuant to the Company's 2014 Long-Term Incentive Plan. The stock options vest 25% on the first anniversary of the date of grant and on a quarterly basis thereafter over a three year period.

Documents

1 file

Issuer

IMMUNOMEDICS INC

CIK 0000722830

Entity typeother

Related Parties

1
  • filerCIK 0001677939

Filing Metadata

Form type
4
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 2:51 PM ET
Size
5.4 KB